These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 6791705)

  • 21. The role of factor XI in thrombin generation induced by low concentrations of tissue factor.
    Keularts IM; Zivelin A; Seligsohn U; Hemker HC; Béguin S
    Thromb Haemost; 2001 Jun; 85(6):1060-5. PubMed ID: 11434685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence exerted by a restricted phospholipid microenvironment on the expression of tissue factor activity at the cell plasma membrane surface.
    Kunzelmann-Marche C; Satta N; Toti F; Zhang Y; Nawroth PP; Morrissey JH; Freyssinet JM
    Thromb Haemost; 2000 Feb; 83(2):282-9. PubMed ID: 10739387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor.
    Hackeng TM; Seré KM; Tans G; Rosing J
    Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3106-11. PubMed ID: 16488980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tissue factor binding of activated factor VII triggers smooth muscle cell proliferation via extracellular signal-regulated kinase activation.
    Cirillo P; Calì G; Golino P; Calabrò P; Forte L; De Rosa S; Pacileo M; Ragni M; Scopacasa F; Nitsch L; Chiariello M
    Circulation; 2004 Jun; 109(23):2911-6. PubMed ID: 15173027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Large enhancement of functional activity of active site-inhibited factor VIIa due to protein dimerization: insights into mechanism of assembly/disassembly from tissue factor.
    Stone MD; Harvey SB; Martinez MB; Bach RR; Nelsestuen GL
    Biochemistry; 2005 Apr; 44(16):6321-30. PubMed ID: 15835921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein S enhances the tissue factor pathway inhibitor inhibition of factor Xa but not its inhibition of factor VIIa-tissue factor.
    Ndonwi M; Broze G
    J Thromb Haemost; 2008 Jun; 6(6):1044-6. PubMed ID: 18419747
    [No Abstract]   [Full Text] [Related]  

  • 27. [Factor XIIa-inhibited diluted thromboplastin time can reflect coagulation process].
    He S; Xiong S; He R; He X; Liu F; Han J; Li J
    Zhonghua Xue Ye Xue Za Zhi; 2000 Mar; 21(3):118-21. PubMed ID: 11876967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitors of factor VIIa affect the interface between the protease domain and tissue factor.
    Carlsson K; Persson E; Carlsson U; Svensson M
    Biochem Biophys Res Commun; 2006 Oct; 349(3):1111-6. PubMed ID: 16970919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue factor: a critical role in inflammation and cancer.
    Lwaleed BA; Cooper AJ; Voegeli D; Getliffe K
    Biol Res Nurs; 2007 Oct; 9(2):97-107. PubMed ID: 17909162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sequential coagulation factor VIIa domain binding to tissue factor.
    Osterlund M; Persson E; Carlsson U; Freskgård PO; Svensson M
    Biochem Biophys Res Commun; 2005 Dec; 337(4):1276-82. PubMed ID: 16236263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of cell proliferation and protease activity by cartilage factors and heparin.
    Hatcher VB; Tsien G; Oberman MS; Burk PG
    J Supramol Struct; 1980; 14(1):33-46. PubMed ID: 7012450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design of protease inhibitors on the basis of substrate stereospecificity.
    Kim DH
    Biopolymers; 1999; 51(1):3-8. PubMed ID: 10380348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein tyrosine kinase activation is required for LPS and PMA induction of tissue factor mRNA in human blood monocytes.
    Ternisien C; Ollivier V; Khechai F; Ramani M; Hakim J; de Prost D
    Thromb Haemost; 1995 Mar; 73(3):413-20. PubMed ID: 7545319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Irreversible pH-denaturation of tissue thromboplastin].
    Zubairov DM; Svintenok GIu; Chenborisova GSh
    Vopr Med Khim; 1991; 37(5):31-3. PubMed ID: 1759393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Fragmentation of human transferrin by proteolytic enzymes].
    Karl M
    Acta Biol Med Ger; 1971; 26(3):599-610. PubMed ID: 4948113
    [No Abstract]   [Full Text] [Related]  

  • 37. The protection of proteolytic enzymes in aqueous suspension, from inactivation by gastric juice.
    Pecile A; Tosi GC; Bandi GL; Previtera MA
    Farmaco Prat; 1967 Dec; 22(12):811-6. PubMed ID: 4888996
    [No Abstract]   [Full Text] [Related]  

  • 38. Studies on Dracunculus medinensis (Linnaeus). II. Effect of acidity on the infective larva.
    Muller R
    J Helminthol; 1971; 45(2):285-8. PubMed ID: 5001302
    [No Abstract]   [Full Text] [Related]  

  • 39. Use of a simple digestive fluid to clear and relax old cestode material for preparation of whole mounts.
    Hsu RG
    J Parasitol; 1968 Feb; 54(1):73. PubMed ID: 4867951
    [No Abstract]   [Full Text] [Related]  

  • 40. [The expression and degradation of tissue thromboplastin].
    Zubairov DM; Popova LG; Evranova GB; Alkhanova NA
    Fiziol Zh SSSR Im I M Sechenova; 1988 Oct; 74(10):1404-8. PubMed ID: 3068077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.